A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Chembio Diagnostics, Inc. -- CEMIon August 7, 2020 at 5:32 pm
The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Chembio Diagnostics, Inc. (NASDAQ: CEMI) ("Chembio") on behalf ...
- ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Chembio Diagnostics, Inc. Investors of Important August 17 Deadline in Securities Class Action – CEMIon August 7, 2020 at 2:45 pm
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc.
- Two Boulder diagnostics companies mergeon August 7, 2020 at 1:27 pm
Merging the companies will allow us to pursue a much larger market opportunity at a much faster pace than either of us could individually," said MBio CEO Chris Myatt in a prepared statement." ...
- Wearable fitness devices deliver early warning of possible COVID-19 infectionon August 7, 2020 at 5:35 am
Fitness information like resting heart rate collected by wearable devices can't diagnose diseases, but it can signal when something is wrong. That can be enough to prompt a COVID-19 test.
- Device Diagnoses Breast Cancer in 60 Minuteson August 5, 2020 at 11:09 pm
Researchers have created a point-of-care device that can provide diagnostic information on the presence of breast cancer in under an hour. In initial validation studies, the device showed an accuracy ...
- A One-Step Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings (1 of 3) (image)on August 5, 2020 at 11:06 am
CytoPAN device (for a point-of-care breast cancer diagnosis). This material relates to a paper that appeared in the Aug. 5, 2020, issue of Science Translational Medicine, published by AAAS.
- Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reachon August 5, 2020 at 8:50 am
Sight Diagnostics has raised $71 million to help expand the commercial reach of its FDA-cleared, tabletop machine for analyzing a finger-prick’s worth of blood.
- Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistanceon August 5, 2020 at 7:29 am
A diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea and rapidly determining in under 30 minutes if the microorganism is susceptible to a single-dose ...
- Sight Diagnostics raises $71 million for blood-testing computer visionon August 5, 2020 at 7:00 am
Sight Diagnostics, a company developing a computer vision-based blood analyzer called Olo, has raised $71 million in venture capital.
- Sight Diagnostics raises another $71M to fully commercialize its blood analyzeron August 5, 2020 at 5:12 am
With this new cash infusion, Sight Diagnostics, which uses machine learning and AI to analyze images of blood samples, has raised a total of $124 million since its inception in 2011.
via Bing News